Summary
The recent Hughes Report outlined the options for redress for those harmed by valproate and pelvic mesh In this blog, AvMa's Chief Executive, Paul Whiteing, discusses the trade-off of redress schemes.
The recent Hughes Report outlined the options for redress for those harmed by valproate and pelvic mesh In this blog, AvMa's Chief Executive, Paul Whiteing, discusses the trade-off of redress schemes.
We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.
Recommended Comments
Create an account or sign in to comment